implementing multi-targeted tyrosine kinase inhibitors in combination with chemo for osteosarcoma
Published 1 year ago • 148 plays • Length 1:03:02
Download video MP4
Download video MP3
Similar videos
-
58:01
combination therapies to improve immune-mediated approaches for osteosarcoma
-
1:43:16
molecularly targeted therapies panel at factor 2023
-
57:33
osteosarcoma institute
-
52:53
overcoming pd-1 inhibitor resistance in metastatic osteosarcoma
-
56:32
pre-targeted approach to delivery of radiopharmaceutical therapy for bone cancer
-
57:14
focal adhesion kinase inhibition to improve losartan-sunitinib immunotherapy in metastatic osteo
-
58:39
osteobites s1 ep23: brian flesner, dvm, ms, dacvim: "adjuvant chemotherapy for canine osteosarcoma ”
-
1:01:13
clinical trials for relapsed or refractory osteosarcoma - the olie study and beyond!
-
1:45:46
immunotherapies panel at factor 2023
-
1:49:15
panel: clinical trials
-
0:24
next episode: clinical trial for osteosarcoma with dr. filemon dela cruz & dr. julia glade-bender
-
46:55
osteobites s1 ep7: matteo trucco, md, osteosarcoma research
-
58:11
osteobites s1 ep22: damon reed, md: "moffitt osteosarcoma research approach ”
-
52:37
osteobites s1 ep5: alex huang, md, phd, osteosarcoma research
-
53:00
osteobites s1 ep25: sulagna banerjee, phd, “modeling osteosarcoma in mice”
-
1:30
mib agents factor 2019 osteosarcoma conference: short version
-
3:21
mib agents factor 2019 osteosarcoma conference
Clip.africa.com - Privacy-policy